Adulterated dietary supplements threaten the health and sporting career of up-and-coming young athletes

Drug Testing and Analysis

Volumn 8, Issue 3-4, 2016, Pages 304-306

  Eichner, Amy ^a   Tygart, Travis ^a  

^a US Anti Doping Agency   (United States)

Author keywords

Adolescent; Adulteration; Anti doping; Contamination; Dietary supplements; Spiking; Sport; Youth

Indexed keywords

FOOD ADDITIVES; NUTRITION; VITAMINS;

ADOLESCENT; ADULTERATION; ANTI-DOPING; SPIKING; YOUTH;

DIETARY SUPPLEMENTS;

ATHLETE; DIET SUPPLEMENTATION; FOOD SAFETY; GOVERNMENT REGULATION; HEALTH; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; NOTE; NUTRITION; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PRODUCT SAFETY; SPORT; ADOLESCENT; DIETARY SUPPLEMENT; DOPING; DRUG CONTAMINATION; STANDARDS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ATHLETES; DIETARY SUPPLEMENTS; DOPING IN SPORTS; DRUG CONTAMINATION; HUMANS; SPORTS; UNITED STATES; YOUNG ADULT;

EID: 84949267132     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1899     Document Type: Note

References (43)

1. H. Geyer, M. K. Parr, K. Koehler, U. Mareck, W. Schänzer, M. Thevis . Nutritional supplements cross-contaminated and faked with doping substances. J. Mass Spectrom. 2008, 43, 892.
2. N. Baume, N. Mahler, M. Kamber, P. Mangin, M. Saugy . Research of stimulants and anabolic steroids in dietary supplements. Scand. J. Med. Sci. Sports. 2006, 16, 41.
3. A. Thomas . Global nutrition and supplements market: history, industry growth, and future trends by persistence market research. Global Newswire, 2015.
4. WADA. Adverse Analytical Findings and Atypical Findings Reported by Accredited Laboratories. World Anti-Doping Agency. Available at: http://www.wada-ama.org/Documents/Science:Medicine/Anti-Doping_Laboratories/Lab_Statistics/WADA_2009_LaboratoryStatisticsReport_Final.pdf [18 August 2015].
5. M. J. Eliason, A. Eichner, A. Cancio, L. Bestervelt, B. D. Adams, P. A. Deuster . Case reports: Death of active duty soldiers following ingestion of dietary supplements containing 1, 3-dimethylamylamine (DMAA). Mil. Med. 2012, 177, 1455.
6. L.V. Karnatovskaia, J.C. Leoni, M.L. Freeman . Cardiac arrest in a 21-year-old man after ingestion of 1, 3-DMAA-containing workout supplement. Clin. J. Sport Med. 2015, 25, e23.
7. T. B. Smith, B. A. Staub, G. M. Natarajan, D. M. Lasorda, I. G. Poornima . Acute myocardial infarction associated with dietary supplements containing 1, 3-dimethylamylamine and Citrus aurantium. Tex. Heart Inst. J. 2014, 41, 70.
8. P. Gee, C. Tallon, N. Long, G. Moore, R. Boet, S. Jackson . Use of recreational drug 1, 3 Dimethylamylamine (DMAA) [corrected] associated with cerebral hemorrhage. Ann. Emerg. Med. 2012, 60, 431.
9. FDA. Q & A: DMAA in Dietary Supplements. Available at: http://www.fda.gov/Food/DietarySupplements/QADietarySupplements/ucm346576.htm [18 August 2015].
10. J. R. Archer, P. I. Dargan, A. M. Lostia, J. van der Walt, K. Henderson, N. Drake, S. Sharma, D. M. Wood, C. J. Walker, A. T. Kicman . Running an unknown risk: a marathon death associated with the use of 1, 3-dimethylamylamine (DMAA). Drug Test. Anal. 2015, 7(5), 433.
11. P. A. Cohen, G. Maller, R. DeSouza, J. Neal-Kababick . Presence of banned drugs in dietary supplements following FDA recalls. JAMA. 2014, 312, 1691.
12. Hearing before Congress: Statement by Senator John McCain on the Dietary Supplement Safety Act of 2010. Available at: http://www.mccain.senate.gov/public/index.cfm/floor-statements?ID=f7c32a83-95c4-8994-4337-84116d678997 [18 August 2015].
13. J. Long . FSMA's role in supplement regulation. Natural Products Insider, 2014. Avilable at: http://www.naturalproductsinsider.com/articles/2014/05/fsma-s-role-in-supplement-regulation.aspx [18 August 2015].
14. Durbin. Press Release. Blumenthal: With Adverse Event Reporting On The Rise, Legislation Needed To Protect Consumers Of Dietary Supplements (2013). Available at: http://www.durbin.senate.gov/newsroom/press-releases/durbin-blumenthal-with-adverse-event-reporting-on-the-rise-legislation-needed-to-protect-consumers-of-dietary-supplements [18 August 2015].
15. M. Cellini, S. Attipoe, P. Seales, R. Gray, A. Ward, M. Stephens, P. A. Deuster . Dietary supplements: physician knowledge and adverse event reporting. Med. Sci. Sports Exerc. 2013, 45, 23.
16. P. Gardiner, D. N. Sarma, T. Low Dog, M. L. Barrett, M. L. Chavez, R. Ko, G. B. Mahady, R. J. Marles, L. S. Pellicore, G. I. Giancaspro . The state of dietary supplement adverse event reporting in the United States. Pharmacoepidemiol. Drug Saf. 2008, 17, 962.
17. FDA Should Take Further Actions to Improve Oversight and Consumer Understanding, GAO-09-250 (2009). Government Accountability Office. Available at: http://www.gao.gov/products/GAO-09-250 [18 August 2015].
18. N. Li, R. Hauser, T. Holford, Y. Zhu, Y. Zhang, B. A. Bassig, S. Honig, C. Chen, P. Boyle, M. Dai, S. M. Schwartz, P. Morey, H. Sayward, Z. Hu, H. Shen, P. Gomery, T. Zheng . Muscle-building supplement use and increased risk of testicular germ cell cancer in men from Connecticut and Massachusetts. Br. J. Cancer. 2015, 112(Suppl), 1247.
19. F. Hartgens, H. Kuipers . Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004, 34, 513.
20. F. C. Wu . Endocrine aspects of anabolic steroids. Clin. Chem. 1997, 43, 1289.
21. R. L. Cunningham, A. R. Lumia, M. Y. McGinnis . Androgenic anabolic steroid exposure during adolescence: ramifications for brain development and behavior. Horm. Behav. 2013, 64, 350.
22. S. M. Berman, R. Kuczenski, J. T. McCracken, E. D. London . Potential adverse effects of amphetamine treatment on brain and behavior: a review. Mol. Psychiatry. 2009, 14, 123.
23. P. A. Cohen, J. C. Travis, B. J. Venhuis . A synthetic stimulant never tested in humans, 1, 3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements. Drug Test. Anal. 2015, 7, 83.
24. P.A. Cohen, C. Bloszies, C. Yee, R. Gerona . An amphetamine isomer whose efficacy and safety in humans has never been studied, beta-methylphenylethylamine (BMPEA), is found in multiple dietary supplements. Drug Test. Anal. 2015, Epub ahead of Print.
25. Promoting safety of medicines for children (2007). Available at: http://www.who.int/medicines/publications/essentialmedicines/Promotion_safe_med_childrens.pdf [18 August 2015].
26. H. A. Spiller, M. C. Beuhler, M. L. Ryan, D. J. Borys, A. Aleguas, G. M. Bosse . Evaluation of Changes in Poisoning in Young Children: 2000 to 2010. Pediatr. Emerg. Care. 2013, 29, 635.
27. S. Dikici, A. Saritas, S. Kilinc, S. Guneysu, H. Gunes . Does an energy drink cause a transient ischemic attack? Am. J. Emerg. Med. 2015, 33, 129 e5-6.
28. CBS News. Teen's death prompts FDA to take aim at powdered caffeine. CBS News. Available at: http://www.cbsnews.com/news/powdered-caffeine-death-fda-legal-action/ [18 August 2015].
29. F. Sanchis-Gomar, H. Pareja-Galeano, G. Cervellin, G. Lippi, C. P. Earnest . Energy drink overconsumption in adolescents: implications for arrhythmias and other cardiovascular events. Can. J. Cardiol. 2015, 31, 572.
30. Committee on Nutrition and the Council on Sports Medicine and Fitness. Clinical Report: Sports drinks and energy drinks for children and adolescents: are they appropriate? Available at: http://www.ncbi.nlm.nih.gov/pubmed/21624882 [18 August 2015].
31. P.A. Cohen, S. Attipoe, J. Travis, M. Stevens, P. Deuster . Caffeine content of dietary supplements consumed on military bases. JAMA Intern. Med. 2013, 173, 592; discussion 594.
32. K. D. Dorsch, A. Bell . Dietary supplement use in adolescents. Curr. Opin. Pediatr. 2005, 17, 653.
33. J. R. Hoffman, A. D. Faigenbaum, N. A. Ratamess, R. Ross, J. Kang, G. Tenenbaum . Nutritional supplementation and anabolic steroid use in adolescents. Med. Sci. Sports Exerc. 2008, 40, 15.
34. P. Shaw, V. Zhang, E. Metallinos-Katsaras . A content analysis of the quantity and accuracy of dietary supplement information found in magazines with high adolescent readership. J. Altern. Complement. Med. 2009, 15, 159.
35. USADA. Supplement 411 High Risk List. US Anti-Doping Agency. Available at: http://www.supplement411.org/hrl/ [18 August 2015].
36. FDA Health Fraud Page. Tainted Supplements (CDER). Food and Drug Administration. Available at: http://www.accessdata.fda.gov/scripts/sda/sdNavigation.cfm?sd=tainted_supplements_cder [18 August 2015].
37. H. Geyer, M. K. Parr, U. Mareck, U. Reinhart, Y. Schrader, W. Schanzer . Analysis of non-hormonal nutritional supplements for anabolic-androgenic steroids - results of an international study. Int. J. Sports Med. 2004, 25, 124.
38. M.K. Parr, H. Geyer, G. Sigmund, K. Kohler, W. Schanzer . Screening of Nutritional Supplements for Stimulants and other Drugs. 21st Cologne Workshop on Doping Analysis, March 16-21. 2003, 11, 67.
39. M. Kamber, N. Baume, M. Saugy, L. Rivier . Nutritional supplements as a source for positive doping cases? Int. J. Sport Nutr. Exerc. Metab. 2001, 11, 258.
40. B. J. Gurley, S. F. Gardner, M. A. Hubbard . Content versus label claims in ephedra-containing dietary supplements. Am. J. Health Syst. Pharm. 2000, 57, 963.
41. P.J. Van Der Merwe, E. Grobbelaar . Inadvertent doping through nutritional supplements is a reality 22nd Cologne Workshop on Dope Analysis, March 7-12. 2004, 12, 69.
42. P. A. Cohen, J. C. Travis, B. J. Venhuis . A methamphetamine analog (N, alpha-diethyl-phenylethylamine) identified in a mainstream dietary supplement. Drug Test. Anal. 2014, 6, 805.
43. S. Martello, M. Felli, M. Chiarotti . Survey of nutritional supplements for selected illegal anabolic steroids and ephedrine using LC-MS/MS and GC-MS methods, respectively. Food Addit. Contam. 2007, 24, 258.